Award
Delivery Order #SPE2DR26F5VNP
Delivery Order for Ustekinumab via AmerisourceBergen under Pharmaceutical Supply IDV
Buyer
Defense Logistics Agency
Award Amount
$4,815.76
Ceiling
$4,815.76
Awarded
March 06, 2026
Period of Performance
Mar 06, 2026 – Mar 27, 2026
Identifier
SPE2DR26F5VNP
NAICS
424210
This award represents a delivery order contract issued under an existing indefinite delivery vehicle (IDV) for pharmaceutical supplies. The recipient, AmerisourceBergen Drug Corp, is a leading healthcare solutions distributor engaged in providing essential pharmaceuticals. This specific delivery order will procure Ustekinumab 90 mg/ml syringe products, critical for targeted medical treatments. The contract plays a significant role in ensuring timely and reliable access to necessary pharmaceuticals for public health initiatives. The scope of work covers the supply and delivery of this specialty medication within a defined short-term timeframe. This delivery order was issued under a competitive umbrella contract structure, leveraging an established IDV awarded through competitive procedures. The performance period is a few weeks commencing in early March 2026, ensuring rapid fulfillment. The broader IDV contract supporting this award facilitates multi-year pharmaceutical supply continuity, enhancing health agency readiness and response.
Description
4571098312!USTEKINUMAB 90 MG/ML SYRINGEML